TechMarketView

First Previous 1 Next Last

Added to list Using AI to fight COVID-19 10/03/2020
in drug discovery in recent years, with a number of UK-based companies leading the way in the field e.g. BenevolentAI of AI/ML). BenevolentAI has identified that baricitinib, which has been approved for rheumatoid arthriti
Added to list Halicin antibiotic discovery showcases value of AI/ML 21/02/2020
discovery. There are many examples including BenevolentAI, Healx and GTN Ltd (Generative Tensorial Networks
Added to list IndustryViews Venture Capital Q3 2019 Review 06/12/2019
Arm BBC BT Dyson Evolyst System C Healthcare Thales Others £100m BenevolentAI AI
Added to list AI-driven Healx raises $56m to fight rare diseases 17/10/2019
databases and proprietary, curated data in a similar way to BenevolentAI (see BenevolentAI raises $115m
Added to list IndustryViews Venture Capital Review Q2 2018 21/09/2018
Channel 4 Arqiva Growth £125m BenevolentAI AI-based drug discovery software Woodford Investment Man
Added to list £200m for new Global Digital Exemplars 06/09/2018
for the UK to lead the way in artificial intelligence was also highlighted. Mentioning BenevolentAI, Babylon Health, Touch Surgery and DeepMind, Hancock
Added to list Funding Trends and Patterns: UK AI/Machine Learning Startups 29/06/2018
like they are securing high levels of funding, BenevolentAI with £115m funding during
Added to list PM setting AI on to early cancer diagnosis 21/05/2018
is a prime and active area for AI/machine learning: BenevolentAI raises $115m to scale-up drug discovery being one recent
Added to list Joanna Shields appointed Group CEO at BenevolentAI 02/05/2018
AI healthcare business BenevolentAI has appointed Baroness Joanna Shields as its new Group CEO at Decru/NetApp, VP at RealNetworks, CEO at Veon and VP at EFI. This is a sound appointment for BenevolentAI in growing bu
Added to list BenevolentAI raises $115m to scale-up drug discovery 19/04/2018
BenevolentAI, the UK start-up applying artificial intelligence (AI) to develop new medicines, has -based, as well as existing investors including Woodford Investment Management. BenevolentAI has now raised in excess of $200m si

First Previous 1 Next Last